hypoglossal nerve stimulation
play

Hypoglossal Nerve Stimulation Jolie Chang, MD Assistant Professor - PDF document

2/11/18 Hypoglossal Nerve Stimulation Jolie Chang, MD Assistant Professor Department of Otolaryngology, Head and Neck Surgery Disclosure None 1 2/11/18 Outline HNS Development WHO: Current clinical criteria for HGNS HOW:


  1. 2/11/18 Hypoglossal Nerve Stimulation Jolie Chang, MD Assistant Professor Department of Otolaryngology, Head and Neck Surgery Disclosure § None 1

  2. 2/11/18 Outline § HNS Development § WHO: Current clinical criteria for HGNS § HOW: Surgical procedure and technique § WHY: Effectiveness of therapy § Future directions OSA § 60-90% patients have multi- level collapse § DISE used to identify major sites of collapse 2

  3. 2/11/18 Upper Airway Muscles in Sleep § Increased Collapsibility • Anatomy • Neuromuscular Control § Genioglossus = UA dilator • Improves upper airway patency • GGEMG declines in sleep – worse in OSA • Activation improves airflow and OSA Genioglossus stimulation § Animal • Electrical stimulation of GG restores airway patency in sleep § Human • GG stimulation associated with ‒ Increased maximum inspiratory airflow, without arousals ‒ Enlargement of retrolingual and retropalatal airway • Distal and proximal hypoglossal nerve stimulation can open airway and improve airflow Schwartz Ar, et al. J. Appl Physiol. 1996. 3

  4. 2/11/18 Pcrit § Genioglossus contraction improves upper airway patency Oliven A, et al. J Appl Physiology. Feb 2003. Stimulation systems § Feasibility trials Schwartz et al. J Appl Physiol 2013. 4

  5. 2/11/18 Hypoglossal Nerve Stimulation § FDA approved first device – Inspire II 4/2014 § Fully implanted system with sleep remote § Unilateral (right) Hypoglossal Nerve stimulation § Synchronized to inspiration Clinical Evidence § STAR Trial: Strollo et al. NEJM 2014. § 126 patients with mod-severe OSA § 12-months post implant § Reduced: • AHI (29.3 to 9) 68% • ODI (25.4 to 7.4) • ESS survey • FOSQ survey • Daily use: 86% 5

  6. 2/11/18 3-year Data AHI 35.0 29.3 30.0 Median AHI 25.0 20.0 15.0 9.7 9.0 10.0 6.2 5.0 0.0 Baseline 12 Month 18 Month 36 Month N=126 N=124 N=121 N=98 Gillespie et al. Otolaryngology-HNS. 2017. Compliance and ESS Gillespie et al. Otolaryngology-HNS. 2017. 6

  7. 2/11/18 Clinical Indications for HGNS § Patient goals and expectations § CPAP intolerance § BMI < 35 § PSG: AHI 15 to 65 • <25% Central apnea § Appropriate airway anatomy: DISE • Rule out complete concentric collapse at the palate § Considerations: • MRI needs • Medical history • Surgical history: Prior implants, prior breast surgery Preoperative evaluation DISE § Rule out complete concentric collapse at soft palate § Vanderveken et al. J Clin Sleep Med 2013: • 21 pts – predictive value of DISE for HGNS outcomes • 16 pts without palate CCC: AHI 38 to 12 • 5 pts with CCC: no change in postop AHI 7

  8. 2/11/18 Intraoperative – Hypoglossal Nerve § NIMS electrodes § Goal: unhindered tongue PROTRUSION and STIFFENING § Include nerve branches for: • Protrusion = oblique and horizontal genioglossi (GG) • Stiffen = intrinsic transverse/vertical (TV) • C1 = geniohyoid (if possible) § Exclude • Retrusion = hyoglossus, styloglossus (HG, SG) NIMS § 18mm paired electrodes § Genioglossus: Floor of mouth § Hyoglossus: lateral tongue 8

  9. 2/11/18 Styloglossus (SG) Hypoglossal Nerve Hyoglossus (HG) § Proximal lateral branches innervate retrusors • Hyoglossus Geniohyoid (GH) S"mula"on Site Genioglossus (GG) • Styloglossus Retractor Muscles Protrusor Muscles § Distal, medial branches innervate protrusors • Genioglossus • Intrinsic T/V § C1 to geniohyoid Dedhia et al. Neuroanatomy of the tongue. Hypoglossal Nerve 9

  10. 2/11/18 Electrode placement 10

  11. 2/11/18 System Validation Postoperative Care § Reduced postoperative pain and medication use § Reduced postoperative hospital stay § CXR § Precautions: no excessive right arm motion, no heavy lifting x 2 weeks § Dressings off POD #2 11

  12. 2/11/18 Activation and Acclimation § 1 month postop § Thresholds • Sensation • Discomfort § Activation Range provided § Patient self titrates over 1 month § Therapy works by balancing functional threshold with arousal threshold and comfort PSG at 2 months 12

  13. 2/11/18 DISE Awake Laryngoscopy with Stimulation 13

  14. 2/11/18 New Devices – Selective Nerve Stimulation § ImThera Medical (Aura6000)- Trial § Current Phase III trial § No DISE requirement § 6 electrodes, circum OSA Surgery Treatment Paradigm § Address anatomic causes of obstruction • Palatine and Lingual Tonsils • Soft palate: UPPP • Parapharyngeal fat, macroglossia: Weight • Epiglottis: epiglottectomy, hyoid suspension, HGNS? • Retrognathia: MMA § HGNS to improve neuromuscular tone in sleep § Patients choice and shared decision making 14

  15. 2/11/18 HGNS Advantages § Addresses reduced neuromuscular tone in OSA § Can be titrated to effect and reprogrammed § Excellent safety profile, low morbidity § Reduced post-operatve pain, faster recovery § Provides multi-level therapy § Good patient adherence over time § Good results in properly selected patients Future of HGNS § Transcutaneous continuous stimulation § New devices, stimulation schemes § Questions • Who is the ideal candidate? • What are the long term effects of chronic stim? • Examine the nonresponders § Personalized medicine: How fit into OSA surgery? • Address anatomic causes: tonsils, weight, craniofacial • HGNS for neuromuscular stim • Shared patient decision making 15

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend